Solara Active Pharma Sciences Ltd (NSE:SOLARAPP1) Share Price

Company Profile

Business description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
Contact
Phase II - CSIR Road
Module No. 601, 602, 603, Ticel Bio Park
Taramani
ChennaiTN600113
IND
T: +91 4447406200
https://www.solara.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,924

Recommended

Our coverage remains overvalued.

Jon Mills, CFA | 14 January 2026

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,151.80	24.70	0.27%
CAC 40	8,350.92	3.72	0.04%
DAX 40	25,289.27	131.39	-0.52%
Dow JONES (US)	49,191.99	398.21	-0.80%
FTSE 100	10,169.17	31.82	0.31%
HKSE	26,999.81	391.33	1.47%
NASDAQ	23,709.87	24.03	-0.10%
Nikkei 225	54,341.23	2,401.34	4.62%
NZX 50 Index	13,757.71	101.66	0.74%
S&P 500	6,963.74	0.00	0.00%
S&P/ASX 200	8,820.60	29.30	0.33%
SSE Composite Index	4,126.09	12.67	-0.31%